Pulmonary delivery of favipiravir in rats reaches high local concentrations without causing oxidative lung injury or sSystemic side effects

Basit Öğe Kaydı
dc.authoridAybige Ertürk / 0000-0002-5179-5865en_US
dc.authorscopusidAybige Ertürk / 57312790100en_US
dc.authorwosidAybige Ertürk / GAQ-1057-2022en_US
dc.contributor.authorAkbal Dağıstan, Özlem
dc.contributor.authorSevim, Mustafa
dc.contributor.authorŞen, Leyla Semiha
dc.contributor.authorBaşarır, Nur Sena
dc.contributor.authorÇulha, Meltem
dc.contributor.authorErtürk, Aybige
dc.contributor.authorFael, Hanan
dc.contributor.authorKaptan, Engin
dc.contributor.authorSancar, Serap
dc.contributor.authorMülazımoğlu Durmuşoğlu, Lütfiye
dc.contributor.authorYeğen, Berrak C
dc.contributor.authorYıldız Peköz, Ayça
dc.date.accessioned2022-12-08T08:14:24Z
dc.date.available2022-12-08T08:14:24Z
dc.date.issued2022en_US
dc.departmentİstinye Üniversitesi, Eczacılık Fakültesi, Eczacılık Teknolojisi Bölümüen_US
dc.description.abstractFavipiravir displays a rapid viral clearance, a high recovery rate and broad therapeutic safety; however, its oral administration was associated with systemic side effects in susceptible patients. Considering that the pulmonary route could provide a high drug concentration, and a safer application with less absorption into systemic circulation, it was aimed to elucidate whether favipiravir delivered via soft-mist inhaler has any deleterious effects on lung, liver and kidney tissues of healthy rats. Wistar albino rats of both sexes (n = 72) were placed in restrainers, and were given either saline or favipiravir (1, 2.5, 5 or 10 mg/kg in 1 mL saline) by inhalation within 2 min for 5 consecutive days. On the 6th day, electrocardiographic recording was obtained, and cardiac blood and lung tissues were collected. Favipiravir did not alter cardiac rhythm, blood cell counts, serum levels of alanine transaminase, aspartate transaminase, blood urea nitrogen, creatinine, urea or uric acid, and did not cause any significant changes in the pulmonary malondialdehyde, myeloperoxidase activity or antioxidant glutathione levels. Our data revealed that pulmonary use of favipiravir via soft-mist inhaler enables a high local concentration compared to plasma without oxidative lung injury or cardiac or hepatorenal dysfunction.en_US
dc.identifier.citationAkbal-Dagistan O, Sevim M, Sen LS, Basarir NS, Culha M, Erturk A, Fael H, Kaptan E, Sancar S, Mulazimoglu Durmusoglu L, Yegen BC, Yildiz-Pekoz A. Pulmonary Delivery of Favipiravir in Rats Reaches High Local Concentrations without Causing Oxidative Lung Injury or Systemic Side Effects. Pharmaceutics. 2022 Nov 4;14(11):2375. doi: 10.3390/pharmaceutics14112375. PMID: 36365193.en_US
dc.identifier.doi10.3390/pharmaceutics14112375.en_US
dc.identifier.issue11en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.urihttps://doi.org/10.3390/pharmaceutics14112375.
dc.identifier.urihttps://hdl.handle.net/20.500.12713/3430
dc.identifier.volume14en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorErtürk, Aybige
dc.language.isoenen_US
dc.publisherMDPIen_US
dc.relation.ispartofPharmaceuticsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCOVID-19en_US
dc.subjectAntiviralen_US
dc.subjectCardiac Toxicityen_US
dc.subjectFavipiraviren_US
dc.subjectHepatotoxicityen_US
dc.subjectInhalationen_US
dc.subjectOxidative Lung Injuryen_US
dc.subjectPulmonary Routeen_US
dc.subjectRenal Toxicityen_US
dc.titlePulmonary delivery of favipiravir in rats reaches high local concentrations without causing oxidative lung injury or sSystemic side effectsen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
pharmaceutics-14-02375.pdf
Boyut:
2.61 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu